Literature DB >> 15053375

Transthoracic lung aspiration in etiology of pneumonia.

K G R Kumar1, Sameer Bakhshi, J C Samantaray, U Banerjee, L S Arya.   

Abstract

Transthoracic lung aspiration was performed in 30 episodes of pneumonia in 27 children with malignancy on chemotherapy to assess etiology of pulmonary infections. Total of 22 organisms were isolated in 16/30 (53.3%) episodes. No acid fast bacilli or Pneumocystis carinii were seen. Organisms grown by blood culture correlated with that of lung puncture in 5 episodes, while throat culture and nasopharyngeal organisms correlated with that of lung puncture on one occasion each. Organisms isolated in 8/18 episodes (44.4%) of antemorten transthoracic aspiration included: Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Streptococcus faecalis and Diphtheroids. In 3/18 episodes, lung puncture results altered treatment and thus resulted in survival of the patients. Only one minor complication occurred in this study--pneumothorax that resolved spontaneously. Thus, transthoracic lung puncture is an useful and safe procedure in immunocompromised patients with pneumonia who do not respond to initial broad spectrum antibiotics.

Entities:  

Mesh:

Year:  2004        PMID: 15053375     DOI: 10.1007/bf02723093

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  4 in total

1.  Needle diagnosis of pneumonitis. Value in high-risk patients.

Authors:  P D Bandt; N Blank; R A Castellino
Journal:  JAMA       Date:  1972-06-19       Impact factor: 56.272

2.  Pneumonia complicating severe underlying disease. A current appraisal of transthoracic lung puncture.

Authors:  C R Gherman; H J Simon
Journal:  Dis Chest       Date:  1965-09

Review 3.  Pulmonary infections in the immunocompromised patient.

Authors:  R A Matthay; W H Greene
Journal:  Med Clin North Am       Date:  1980-05       Impact factor: 5.456

4.  Needle aspiration of the lung in complex pneumonias.

Authors:  D L Palmer; M Davidson; R Lusk
Journal:  Chest       Date:  1980-07       Impact factor: 9.410

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.